Princeton Capital Management’s NEOPHOTONICS CORP NPTN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-26,040
Closed -$400K 114
2021
Q4
$400K Sell
26,040
-4,480
-15% -$58.9K 0.11% 83
2021
Q3
$266K Buy
30,520
+1,258
+4% +$11.5K 0.08% 90
2021
Q2
$299K Buy
29,262
+1,115
+4% +$11.8K 0.09% 89
2021
Q1
$336K Hold
28,147
0.11% 83
2020
Q4
$256K Sell
28,147
-3,607
-11% -$27.9K 0.09% 91
2020
Q3
$193K Hold
31,754
0.08% 90
2020
Q2
$282K Buy
31,754
+9,264
+41% +$79.9K 0.13% 77
2020
Q1
$184K Sell
22,490
-16,240
-42% -$120K 0.1% 82
2019
Q4
$290K Sell
38,730
-1,500
-4% -$11.2K 0.13% 77
2019
Q3
$245K Hold
40,230
0.12% 78
2019
Q2
$168K Hold
40,230
0.08% 94
2019
Q1
$253K Sell
40,230
-1,241
-3% -$8.69K 0.13% 79
2018
Q4
$269K Sell
41,471
-3,400
-8% -$26K 0.16% 72
2018
Q3
$372K Buy
44,871
+1,354
+3% +$10.3K 0.15% 73
2018
Q2
$271K Hold
43,517
0.12% 83
2018
Q1
$298K Buy
43,517
+13,900
+47% +$88.3K 0.13% 77
2017
Q4
$195K Buy
+29,617
New +$181K 0.09% 91

Other funds holding NPTN

Princeton Capital Management's NPTN Position: Q1 2022 in Review

Princeton Capital Management sold out of NEOPHOTONICS CORP (NPTN) in Q1 2022, closing a stake of 26,040 shares — an estimated $400K sold.

Princeton Capital Management first reported a position in NPTN in Q4 2017 and held it in 17 quarters. The position peaked at $400K in Q4 2021. 143 funds tracked by Wall St. Rank hold NPTN as of Q1 2022.

  • Princeton Capital Management reported no remaining NEOPHOTONICS CORP position as of Q1 2022 after selling out during the quarter.
  • Princeton Capital Management sold 26,040 NEOPHOTONICS CORP shares in Q1 2022, an estimated $400K.
  • Princeton Capital Management first reported a position in NEOPHOTONICS CORP in Q4 2017 and held it in 17 quarters.
  • Princeton Capital Management's NEOPHOTONICS CORP position peaked at $400K in Q4 2021.
  • 143 funds tracked by Wall St. Rank held NEOPHOTONICS CORP as of Q1 2022.

Based on Princeton Capital Management's 13F filing for Q1 2022, filed 11 May 2022.